Ixabepilone (INN; also known as azaepothilone B, codenamed BMS-247550) is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer.<\/p>\n
On October 16, 2007, the U.S. Food and Drug Administration approved ixabepilone for the treatment of aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies. In November 2008, the EMEA has refused a marketing authorisation for Ixabepilone. Ixabepilone is administered through injection, and is marketed under the trade name Ixempra.<\/p>\n
If IXEMPRA Kit (ixabepilone) for Injection<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n XEMPRA is a prescription medicine. IXEMPRA is used to treat breast cancer. \u2022 IXEMPRA, a microtubule inhibitor, in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane. \u2022 IXEMPRA as monotherapy is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline, a taxane and capecitabine. .<\/p>\n Source content :\u00a0www.accessdata.fda.gov<\/a><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection\u201d <\/strong> based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n IXEMPRA Kit<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n ixabepilone<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u00a0\u2022 IXEMPRA for injection, 15 mg supplied with DILUENT for IXEMPRA, 8 mL
\n\u2022 IXEMPRA for injection, 45 mg supplied with DILUENT for IXEMPRA, 23.5 mL<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n R-Pharm<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n